The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
Abstract Background The pattern recognition receptor long pentraxin-3 (PTX3) plays conflicting roles in cancer by acting as an oncosuppressor or as a pro-tumor mediator depending on tumor context. Triple negative breast cancer (TNBC) represents the most aggressive histotype of breast cancer, charact...
| Published in: | Experimental Hematology & Oncology |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-09-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-023-00441-y |
